March 10, 2024 Bausch + Lomb Corporation announced that Karen L. Ling has been appointed to its board of directors, effective immediately. Current director Richard De Schutter will retire from the board effective as of the company’s 2024 Annual Meeting of Shareholders. With Ms. Ling’s appointment, the board has been temporarily expanded to 11 members and is expected to revert to 10 directors following the Annual Meeting.

Ms. Ling is the former executive vice president and chief human resources officer at American International Group Inc. and, prior to that, at Allergan. She previously held senior human resources roles at Merck and Wyeth. Ms. Ling is currently a director, and chair of the compensation and human capital management committee, of iRythym Technologies and has served on the boards of Mallinckrodt Plc and TherapeuticsMD Inc.